Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00843843 · ClinicalTrials.gov registry record · NA

Sleep Length and Circadian Regulation in Humans

A NA study of Sleep Disorders, sponsored by Rush University Medical Center.

Completed
Registry status
NA
Development phase
16
Enrollment target
1
Study location

NCT00843843 is a NA study of Sleep Disorders that has completed, run by Rush University Medical Center. The registered enrollment target is 16 participants, below the 328-participant average among 19 other Sleep Disorders trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00843843, a NA study of Sleep Disorders, has completed, sponsored by Rush University Medical Center.

COMPLETED
Registry status
NA
Development phase
16 participants
Enrollment target
1
Study location

Study Summary

This research will examine why sleep restriction reduces the body clock's response to bright light. The results will enable the optimization of the bright light treatment of people who suffer from circadian rhythm sleep disorders, which include shift work sleep disorder, jet lag, delayed sleep phase syndrome and winter depression, thereby improving public health and safety, well-being, mood, mental function, and quality of life.

Conditions Studied

Interventions

  • DEVICE Bright light box

Study Locations (1)

Illinois

  • Biological Rhythms Research Laboratory, RUMC - Chicago

Trial Details

FieldValue
Enrollment Target 16 participants
Start Date 2008-03
Est. Completion 2014-02
Phase NA

Sponsor

Rush University Medical Center

320 total trials

What the Registry Record Tells You About NCT00843843

The ClinicalTrials.gov registry entry for NCT00843843 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 328-participant average among 19 other Sleep Disorders trials with a reported enrollment target (95% lower). The listed sponsor is Rush University Medical Center, which has 320 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Sleep Disorders appearing as the primary indexed condition, and to 1 intervention - of which Bright light box is the first listed.

NCT00843843 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.

Frequently Asked Questions

What is clinical trial NCT00843843 about?

NCT00843843 is a clinical study titled "Sleep Length and Circadian Regulation in Humans". This research will examine why sleep restriction reduces the body clock's response to bright light. The results will enable the optimization of the bright light treatment of people who suffer from circadian rhythm sleep disorders, which include shift work sleep disorder, jet lag, delayed sleep phase...

What is the current status of trial NCT00843843?

This trial is currently completed. It is a NA study. The enrollment target is 16 participants. The study started on 2008-03. Estimated completion is 2014-02.

What conditions does trial NCT00843843 study?

This clinical trial studies the following conditions: Sleep Disorders.

What interventions are being tested in trial NCT00843843?

The interventions under investigation include: Bright light box (DEVICE).

Who is sponsoring clinical trial NCT00843843?

This trial is sponsored by Rush University Medical Center, which has 320 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00843843 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Sleep Disorders

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.